Goldman Sachs Group Inc Night Hawk Biosciences, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Night Hawk Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,394 shares of NHWK stock, worth $2,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,394
Previous 14,175
1.54%
Holding current value
$2,303
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NHWK
# of Institutions
8Shares Held
58.7KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X028.8KShares$4,6070.0% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M10.1KShares$1,6210.0% of portfolio
-
Cutler Group LP5KShares$8000.0% of portfolio
-
Huntington National Bank Columbus, OH220Shares$350.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ100Shares$160.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...